In type 2 diabetes, chronic hyperglycemia activates NLRP3 inflammasome by promoting the generation of ROS; then, IL-1β induces the dysfunction and destruction of pancreatic islet β cells (16). This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.